NeoGenomics(NEO)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

NEO NeoGenomics

已收盘 07-09 16:00:00 EDT

14.73

+0.49

+3.44%

盘后14.73

+0.000.00%

16:46 EDT

最高14.94	最低14.17	成交量151.73万
今开14.25	昨收14.24	日振幅5.44%
总市值19.17亿	流通市值17.38亿	总股本1.30亿
成交额2,230万	换手率1.29%	流通股本1.18亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"NEO","market":"US","secType":"STK","nameCN":"NeoGenomics","latestPrice":14.73,"timestamp":1783627200000,"preClose":14.24,"halted":0,"volume":1517267,"hourTrading":{"tag":"盘后","latestPrice":14.73,"preClose":14.73,"latestTime":"16:46 EDT","volume":40724,"amount":599863.32,"timestamp":1783630001208,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.034410112359550576,"floatShares":118000000,"shares":130143833,"eps":-0.771755,"marketStatus":"已收盘","change":0.49,"latestTime":"07-09 16:00:00 EDT","open":14.25,"high":14.94,"low":14.165,"amount":22302817.434712,"amplitude":0.054424,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.771755,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1783670400000},"marketStatusCode":5,"adr":0,"adrRate":0,"listingDate":1355115600000,"exchange":"NASDAQ","adjPreClose":14.24,"preHourTrading":{"tag":"盘前","latestPrice":14.33,"preClose":14.24,"latestTime":"09:28 EDT","volume":48841,"amount":696712.029741,"timestamp":1783603680027,"change":0.09,"changeRate":0.00632,"amplitude":0.02809},"postHourTrading":{"tag":"盘后","latestPrice":14.73,"preClose":14.73,"latestTime":"16:46 EDT","volume":40724,"amount":599863.32,"timestamp":1783630001208,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.531869,"impliedVol":0.6975,"impliedVolPercentile":0.8127},"requestUrl":"/m/hq/s/NEO","defaultTab":"news","newsList":[{"id":"2650241439","title":"NeoGenomics推出FDA批准的前列腺癌伴随诊断试剂","url":"https://stock-news.laohu8.com/highlight/detail?id=2650241439","media":"环球市场播报","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2650241439?lang=zh_cn&edition=full","pubTime":"2026-07-09 20:46","pubTimestamp":1783601160,"startTime":"0","endTime":"0","summary":"NeoGenomics公司宣布推出PTEN IHC CDx检测试剂，这是美国FDA批准的首款用于前列腺腺癌患者的免疫组织化学伴随诊断试剂。TRUQAP近期已获FDA批准上市。　　该检测由NeoGenomics旗下全国肿瘤实验室网络的病理学家执行，单独下单时通常在一至两天内出具结果，已获纽约州批准使用。　　NeoGenomics医疗服务副总裁Nathan Montgomery表示，治疗侵袭性前列腺癌的临床医生长期需要靶向疗法及配套的筛选工具，此次将PTEN IHC CDx整合入NEO PanTracer Pro，为社区肿瘤诊所提供了经FDA批准的伴随诊断选择。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-07-09/doc-inihfihu7566436.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4121","BK4196","FBT","LABU","LU0106261612.USD","LU0012050646.USD","NEO","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648796669","title":"据印度国家证券交易所数据显示，NEO APEX股票经纪有限责任合伙企业通过大宗交易，以每股42.42卢比的价格购入韦丹塔","url":"https://stock-news.laohu8.com/highlight/detail?id=2648796669","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648796669?lang=zh_cn&edition=full","pubTime":"2026-07-03 21:49","pubTimestamp":1783086593,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4196","LU0012050646.USD","APEX","FBT","BK4121","LU0106261612.USD","BK4582","IAI","NEO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1190600181","title":"NeoGenomics：部分收益及现金或用于回购至多2500万美元流通普通股","url":"https://stock-news.laohu8.com/highlight/detail?id=1190600181","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1190600181?lang=zh_cn&edition=full","pubTime":"2026-06-17 18:03","pubTimestamp":1781690592,"startTime":"0","endTime":"0","summary":"NeoGenomics公司表示，其部分收益及可用现金或将用于回购价值不超过2500万美元的流通普通股。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","BK4196","LU0012050646.USD","NEO","LU0106261612.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638154592","title":"NeoGenomics将亮相ASCO年会 展示八项癌症检测新研究","url":"https://stock-news.laohu8.com/highlight/detail?id=2638154592","media":"环球市场播报","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638154592?lang=zh_cn&edition=full","pubTime":"2026-05-26 23:08","pubTimestamp":1779808080,"startTime":"0","endTime":"0","summary":"领先的癌症诊断解决方案提供商NeoGenomics今日宣布，将在2026年美国临床肿瘤学会年会上展示八项科学摘要，重点呈现公司在微小残留病检测、精准肿瘤学及真实世界证据等领域的最新进展。本次ASCO年会将于5月29日至6月2日在芝加哥举行。　　从财务表现来看，NeoGenomics正保持稳健增长。投资者将密切关注本次ASCO年会上相关研究成果的反馈，以及其对NGS业务增长和毛利率改善的潜在推动。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-05-26/doc-inhzfwqk1331967.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4196","LU0012050646.USD","LU0106261612.USD","NEO","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631545526","title":"中国南方航空股份(01055)购买102架A320 NEO系列飞机","url":"https://stock-news.laohu8.com/highlight/detail?id=2631545526","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631545526?lang=zh_cn&edition=full","pubTime":"2026-04-29 22:50","pubTimestamp":1777474239,"startTime":"0","endTime":"0","summary":"智通财经APP讯，中国南方航空股份(01055)发布公告，于2026年4月29日，本公司与空中客车公司订立飞机收购协议，以自空中客车公司购买102架A320 NEO系列飞机;厦门航空有限公司，即本公司拥有 55%股权的附属公司，与空中客车公司订立飞机收购协议，以自空中客车公司购买 35 架 A320 NEO 系列飞机。董事们认为，诸如粤港澳大湾区发展、京津冀协同发展以及“一带一路”联合建设等重大国家战略，为本集团带来了更广阔的发展机遇。本集团积极把握这些发展机遇，保持运力份额的稳定增长，并优化机队结构。此次收购将通过提升本集团的运力，增强其市场竞争力。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1436721.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4196","BK1561","BK1123","01055","BK4121","LU0012050646.USD","LU0106261612.USD","BK1514","NEO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183178879","title":"Leerink Partners上调NeoGenomics评级至跑赢大盘 目标价大幅调升至25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1183178879","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1183178879?lang=zh_cn&edition=full","pubTime":"2026-04-29 19:33","pubTimestamp":1777462396,"startTime":"0","endTime":"0","summary":"投资机构Leerink Partners宣布将癌症检测公司NeoGenomics的股票评级从\"与大市持平\"上调至\"跑赢大盘\"，同时将其目标股价从12美元大幅提升至25美元，显示出对该公司在肿瘤基因检测领域发展前景的强烈信心。\n此次评级调整反映了分析师对NeoGenomics业务转型和增长潜力的重新评估。目标价的大幅上调表明Leerink Partners认为该公司当前股价尚未充分反映其未来价值，预计其股价将有显著上行空间。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4121","NEO","BK4196","LU0106261612.USD","LU0012050646.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629829005","title":"观察｜在“新”与“变”中，经济中心城市如何挑大梁","url":"https://stock-news.laohu8.com/highlight/detail?id=2629829005","media":"澎湃新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629829005?lang=zh_cn&edition=full","pubTime":"2026-04-23 11:12","pubTimestamp":1776913948,"startTime":"0","endTime":"0","summary":"澎湃新闻记者邹娟见习记者洪旭东“十五五”开局，上海经济运行起势有力、向上向好。4月22日，上海公布一季度经济数据：全市生产总值达到13526.91亿元，同比增长5.9%，高于全国0.9个百分点，实现“开门红”，在全国发展大局中发挥了经济中心城市挑大梁作用。重点行业实现均衡增长。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202604233715723314.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604233715723314.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU0106261612.USD","NEO","BK4196","BK4121","LU0012050646.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623348893","title":"道达尔能源完成英国上游业务合并，成立新公司NEO NEXT+","url":"https://stock-news.laohu8.com/highlight/detail?id=2623348893","media":"环球市场播报","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623348893?lang=zh_cn&edition=full","pubTime":"2026-03-30 20:43","pubTimestamp":1774874580,"startTime":"0","endTime":"0","summary":"道达尔能源已完成其英国上游油气业务与NEO NEXT的合并，成立了一家名为NEO NEXT+的新公司，并在合并后的实体中持有47.5%的股份。　　该交易使NEO NEXT+成为英国大陆架上最大的独立油气生产商，预计2026年的日产量将超过25万桶油当量。　　根据此前披露的条款，在所有权结构方面，道达尔能源持有NEO NEXT+ 47.5%的股份，HitecVision持有28.875%，雷普索尔持有23.625%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-03-30/doc-inhsuquq3875012.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4561","BK4196","LU2237443382.USD","LU0012050646.USD","BK4121","NEXT","LU0106261612.USD","BK4588","159945","BK4585","TTE","NEO","BK4201","LU2129689514.USD","LU2237443549.SGD","LU2237443895.HKD","LU2237443622.USD","LU2129689605.HKD","BK4144","LU2237443978.SGD","LU2129689431.USD","LU2237443465.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518439713","title":"光线传媒12.2亿收购奥林NEO项目，东方资产、翰同资本成功退出","url":"https://stock-news.laohu8.com/highlight/detail?id=2518439713","media":"微博财经-财道工作室","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518439713?lang=zh_cn&edition=full","pubTime":"2025-03-11 16:38","pubTimestamp":1741682280,"startTime":"0","endTime":"0","summary":"光线传媒近日公告计划斥资12.2亿元收购北京奥林NEO办公楼，交易对手为东方资产、翰同资本等。尽管当前办公楼市场面临一定空置率压力，但光线传媒对奥林NEO项目的升值空间仍表达了乐观态度。本次出售奥林NEO有助于东方资产进一步改善资产流动性，加快投资收益落袋。今年2月，东方资产公告控股股东变更为中央汇金公司。此次光线传媒承债式收购奥林NEO，意味着大连银行的信贷资金将得到保证。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/wbstock/2025-03-11/doc-inephnhf9666802.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0083","BK0188","BK0200","BK0049","BK0267","NEO","BK4196","LU0106261612.USD","BK0098","BK4121","LU0012050646.USD","BK0087","BK0108","300251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518879284","title":"《哪咤2》爆火后 光线传媒12.2亿收购北京奥林NEO办公楼","url":"https://stock-news.laohu8.com/highlight/detail?id=2518879284","media":"观点网","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518879284?lang=zh_cn&edition=full","pubTime":"2025-03-10 00:25","pubTimestamp":1741537512,"startTime":"0","endTime":"0","summary":"3月7日晚，光线传媒发布购买资产公告，宣布将斥资12.2亿元购买北京棫霖企业管理有限公司100%股权，从而取得位于北京市朝阳区的北京奥林NEO大楼作为办公场所。根据公司2024年三季报显示，光线传媒期内营业收入仅有14.42亿元，归母净利润为4.61亿元，扣非归母净利润为4.33亿元。也就是说，光线传媒实质上是买下了北京奥林NEO这座办公楼。根据公司披露的交易公告，光线传媒此次收购奥林NEO项目所涉及的全部款项合计人民币12.20亿元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/03/10002548615300.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LU0012050646.USD","BK0083","BK0188","BK0108","LU0106261612.USD","BK0098","BK0087","NEO","BK4196","BK4121","BK0200","BK0049","300251","BK0267"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514029642","title":"券商晨会精华 | NEO Gamma人形机器人发布 新材料应用迎催化","url":"https://stock-news.laohu8.com/highlight/detail?id=2514029642","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514029642?lang=zh_cn&edition=full","pubTime":"2025-02-26 08:24","pubTimestamp":1740529470,"startTime":"0","endTime":"0","summary":"银河证券表示，机场板块层面，当前机场板块对于免税协议重签扣点率下降的悲观情绪基本已被priced in。","market":"sh","thumbnail":"https://img.zhitongcaijing.com/image/20250226/20250226082453_33926.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20250226/20250226082453_33926.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1254384.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["LU0012050646.USD","LU0106261612.USD","NEO","BK4196","159703","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1121407072","title":"异动解读 | NeoGenomics盘中大涨5.20%,分析师看好公司前景","url":"https://stock-news.laohu8.com/highlight/detail?id=1121407072","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1121407072?lang=zh_cn&edition=full","pubTime":"2025-02-20 00:24","pubTimestamp":1739982268,"startTime":"0","endTime":"0","summary":"NeoGenomics(NEO)公司今日盘中股价大涨5.20%,引发市场关注。\n分析人士指出,这很可能与华尔街分析师看好该公司前景有关。路透社报道,杰富瑞(JEF)分析师将NeoGenomics的目标价从22美元下调至18美元,反映出分析师仍然对该公司持相对乐观态度。\nNeoGenomics是一家癌症诊断和生物疗法公司,行业前景广阔。虽然面临诸多不确定性,但有分析师维持中性评级并上调目标价,表明公司业务仍备受看好。投资者对NeoGenomics长期增长前景持乐观态度,推动其盘中大涨。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"异动解读 | NeoGenomics盘中大涨5.20%,分析师看好公司前景","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["NEO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512848814","title":"Neogenomics, Inc.盘中异动 早盘急速拉升5.12%报13.04美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512848814","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512848814?lang=zh_cn&edition=full","pubTime":"2025-02-20 00:22","pubTimestamp":1739982152,"startTime":"0","endTime":"0","summary":"北京时间2025年02月20日00时22分，Neogenomics, Inc.股票出现波动，股价大幅拉升5.12%。截至发稿，该股报13.04美元/股，成交量55.049万股，换手率0.43%，振幅9.83%。Neogenomics, Inc.股票所在的生命科学行业中，整体涨幅为0.87%。Neogenomics, Inc.公司简介：NeoGenomics Inc 在美国运营着一个以癌症为重点的基因检测实验室网络，并在瑞士运营着一个实验室。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220002232988b4324&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250220002232988b4324&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","BK4196","LU0012050646.USD","LU0106261612.USD","NEO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512102631","title":"B of A Securities：维持NeoGenomics(NEO.US)评级，由中性调整至中性评级, 目标价由19.00美元调整至16.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2512102631","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512102631?lang=zh_cn&edition=full","pubTime":"2025-02-19 21:21","pubTimestamp":1739971312,"startTime":"0","endTime":"0","summary":"B of A Securities：维持NeoGenomics(NEO.US)评级，由中性调整至中性评级, 目标价由19.00美元调整至16.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/19212148266507.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["NEO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512165115","title":"Neogenomics, Inc.盘中异动 早盘股价大跌10.61%报12.89美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512165115","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512165115?lang=zh_cn&edition=full","pubTime":"2025-02-18 22:31","pubTimestamp":1739889091,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日22时31分，Neogenomics, Inc.股票出现异动，股价大幅跳水10.61%。Neogenomics, Inc.股票所在的生命科学行业中，整体跌幅为0.03%。其相关个股中，Genedx Holdings Corp.、Prophase Labs, Inc.、燃石医学涨幅较大，Prophase Labs, Inc.、Check-Cap Ltd.、Mainz Biomed N.V.较为活跃，换手率分别为61.77%、1.36%、0.79%，振幅较大的相关个股有Grail, Inc.、Neogenomics, Inc.、Twist Bioscience Corporation，振幅分别为4.34%、2.59%、2.45%。Neogenomics, Inc.公司简介：NeoGenomics Inc 在美国运营着一个以癌症为重点的基因检测实验室网络，并在瑞士运营着一个实验室。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218223131a24aac74&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218223131a24aac74&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4121","BK4196","LU0012050646.USD","LU0106261612.USD","NEO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1166373264","title":"异动解读 | NeoGenomics每股收益大超预期,股价盘前大涨5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=1166373264","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1166373264?lang=zh_cn&edition=full","pubTime":"2025-02-18 20:10","pubTimestamp":1739880615,"startTime":"0","endTime":"0","summary":"NeoGenomics公司(股票代码:NEO)2025年2月18日周二盘前股价大涨5.06%,引发了投资者的广泛关注。\n\n据悉,NeoGenomics公司2024年第四季度财报数据优于预期,尤其是公司每股收益远高于分析师的预期,这可能是导致该公司股价大涨的主要原因。\n\n公司2024年第四季度实现调整后每股收益0.04美元,高于分析师一致预期的0.03美元,环比增长33.33%。而公司当季度销售额虽然小幅低于预期,但仍同比增长10.57%,达到1.72亿美元。盈利数据的优异表现令市场对该公司的发展前景看好,带动了公司股价在盘前大涨。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["NEO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1123802248","title":"NeoGenomics 2024年第四季度调整后每股收益$0.04，超出预期的$0.03，销售额为$1.72亿，不及预期的$1.7318亿","url":"https://stock-news.laohu8.com/highlight/detail?id=1123802248","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1123802248?lang=zh_cn&edition=full","pubTime":"2025-02-18 20:06","pubTimestamp":1739880403,"startTime":"0","endTime":"0","summary":"NeoGenomics报告季度每股收益为0.04美元，高于分析师一致预期的0.03美元，超出33.33%。公司报告季度销售额为1.72亿美元，低于分析师一致预期的1.7318亿美元，低出0.68%。这比去年同期的销售额1.5555亿美元增加了10.57%。以上内容来自Benzinga Earnings专栏，原文如下：$NeoGenomics$  reported quarterly earnings of $0.04 per share which beat the analyst consensus estimate of $0.03 by 33.33 percent. This is a 33.33 percent increase over earnings of $0.03 per share from the same period last year.  The company reported quarterly sales of $172.00 million which missed the analyst consensus estimate of $173.18 ","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"NeoGenomics 2024年第四季度调整后每股收益$0.04，超出预期的$0.03，销售额为$1.72亿，不及预期的$1.7318亿","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NEO"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2511195692","title":"Neogenomics, Inc.盘中异动 早盘股价大涨5.02%报14.61美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511195692","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511195692?lang=zh_cn&edition=full","pubTime":"2025-02-14 23:53","pubTimestamp":1739548406,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日23时53分，Neogenomics, Inc.股票出现波动，股价急速上涨5.02%。截至发稿，该股报14.61美元/股，成交量18.216万股，换手率0.14%，振幅4.67%。Neogenomics, Inc.股票所在的生命科学行业中，整体涨幅为0.79%。Neogenomics, Inc.公司简介：NeoGenomics Inc 在美国运营着一个以癌症为重点的基因检测实验室网络，并在瑞士运营着一个实验室。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021423532798859ce5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021423532798859ce5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0012050646.USD","BK4196","LU0106261612.USD","BK4121","NEO"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.neogenomics.com","stockEarnings":[{"period":"1week","weight":-0.0488},{"period":"1month","weight":0.3005},{"period":"3month","weight":0.7935},{"period":"6month","weight":0.0821},{"period":"1year","weight":0.9114},{"period":"ytd","weight":0.2109}],"compareEarnings":[{"period":"1week","weight":-0.0005},{"period":"1month","weight":0.0084},{"period":"3month","weight":0.0963},{"period":"6month","weight":0.074},{"period":"1year","weight":0.2016},{"period":"ytd","weight":0.0931}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Neogenomics, Inc.于1988年10月29日在内华达州注册成立。该公司专门从事癌症遗传学测试和信息服务，为医生提供世界上最全面的以肿瘤为中心的测试菜单之一，帮助他们诊断和治疗癌症。公司的药物服务部为制药客户提供临床试验和药物开发服务。1998年10月29日，母公司作为美国通信企业有限公司在内华达州注册成立，母公司在2001年12月14日更名为Neogenomics, Inc.。","yearOnYearQuotes":[{"month":1,"riseRate":0.428571,"avgChangeRate":0.004357},{"month":2,"riseRate":0.5,"avgChangeRate":0.012062},{"month":3,"riseRate":0.428571,"avgChangeRate":-0.038488},{"month":4,"riseRate":0.357143,"avgChangeRate":-0.024148},{"month":5,"riseRate":0.642857,"avgChangeRate":0.046304},{"month":6,"riseRate":0.714286,"avgChangeRate":0.064446},{"month":7,"riseRate":0.785714,"avgChangeRate":0.08659},{"month":8,"riseRate":0.461538,"avgChangeRate":0.036189},{"month":9,"riseRate":0.307692,"avgChangeRate":-0.023669},{"month":10,"riseRate":0.615385,"avgChangeRate":0.070403},{"month":11,"riseRate":0.692308,"avgChangeRate":0.100243},{"month":12,"riseRate":0.230769,"avgChangeRate":-0.03319}],"exchange":"NASDAQ","name":"NeoGenomics","nameEN":"NeoGenomics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"NeoGenomics(NEO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供NeoGenomics(NEO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"NeoGenomics,NEO,NeoGenomics股票,NeoGenomics股票老虎,NeoGenomics股票老虎国际,NeoGenomics行情,NeoGenomics股票行情,NeoGenomics股价,NeoGenomics股市,NeoGenomics股票价格,NeoGenomics股票交易,NeoGenomics股票购买,NeoGenomics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"NeoGenomics(NEO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供NeoGenomics(NEO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}